Frontage Expands Genomics Services Through the Acquisition of Ocean Ridge Biosciences News provided by Share this article Share this article EXTON, Pa., April 19, 2021 /PRNewswire/ -- Frontage Laboratories, Inc. today announced the acquisition of Ocean Ridge Biosciences. Ocean Ridge Biosciences, located in Deerfield Beach, Florida, provides genomic services to clients developing novel therapeutics, including complete service solutions for analysis of RNA expression, DNA polymorphisms, methylation, microbial composition, and protein biomarkers from a wide range of samples. The company's wet lab services are optimized for ultra-low input requirements and challenging sample types such as formalin-fixed paraffin-embedded tissues, skin swabs, and a variety of biofluids. Some of the core applications includes mechanism of action, lead optimization, biomarker discovery, and development of companion diagnostics.